AI Bias Analysis
4 models · Takes ~15 seconds
(MedPage Today) -- DENVER -- Adding a GLP-1 agonist to psoriasis medication significantly improved outcomes in patients with psoriatic arthritis (PsA) and overweight or obesity, a phase III randomized trial showed. After 36 weeks, almost a third...
Source
MedPage Today
Opens original article in a new tab
Takeda Pharmaceuticals, the largest biopharma in Mass., will lay off 250 workers in Cambridge beginning in July.
(MedPage Today) -- NEW ORLEANS -- The beta-blockers routinely used after myocardial infarction (MI) can be reasonably stopped after a year in some patients, the SMART-DECISION trial found. In stabilized heart attack survivors without heart failure...
(MedPage Today) -- More than 8 million people will be at risk of losing their Medicaid coverage once the Medicaid work requirement passed as part of last year's reconciliation bill is fully implemented by the states, a study found. Among a population...
(MedPage Today) -- The antidepressant fluvoxamine delivered clinically relevant reductions in long COVID fatigue, but the diabetes drug metformin didn't outdo placebo, according to the randomized REVIVE-TOGETHER trial. Among 399 adults with long...